| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/11/2009 | EP2021003A2 Imidazoazephinone compounds |
| 02/11/2009 | EP2020873A2 Food products for hypophosphoric normo-, hyper- and hypoproteic diets, and their use for nutrition of subjects in need of a low phosphorus level diet |
| 02/11/2009 | EP1549950B1 Methods for identifying glucose uptake modulators |
| 02/11/2009 | EP1478236B1 Targeted retrograde gene delivery to motor neurons |
| 02/11/2009 | EP1370561B1 Tetrahydro-pyrazino[1,2-a]indoles for the treatment of central nervous disorders |
| 02/11/2009 | CN101365490A Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
| 02/11/2009 | CN101365476A Combined use of dpp iv inhibitors and gastrin compounds |
| 02/11/2009 | CN101365470A Compositions and methods for treatment of diabetes |
| 02/11/2009 | CN101365463A Antacid |
| 02/11/2009 | CN101365442A Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
| 02/11/2009 | CN101365441A Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
| 02/11/2009 | CN101365434A Treatment of type 2 diabetes with a combination of DPIV inhibitor and metformin or thiazolidinedione |
| 02/11/2009 | CN101365432A Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| 02/11/2009 | CN101365431A Novel use of nutraceutical compositions comprising resveratrol |
| 02/11/2009 | CN101362773A Heterocyclic boronic acid compounds |
| 02/11/2009 | CN101362731A Heterocyclic compounds and methods of use |
| 02/11/2009 | CN101361967A Y2/Y4 selective receptor agonists for therapeutic interventions |
| 02/11/2009 | CN101361962A New use of thymosin alpha1 |
| 02/11/2009 | CN101361933A Preparation method of hypoglycemic granules |
| 02/11/2009 | CN101361907A Hypoglycemic, antihypertensive formulation and preparation technique thereof |
| 02/11/2009 | CN101361886A Chinese herbal medicine extract with lipase activity inhibition and new use thereof |
| 02/11/2009 | CN101361854A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361853A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361852A Medicine composition for preventing the birth defect and improving the memory and intelligence |
| 02/11/2009 | CN101361841A Use of traditional Chinese medicine in preparing medicine for treating diabetes cardiomyopathy |
| 02/11/2009 | CN101361838A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361837A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361836A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361835A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361834A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361833A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361832A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361821A Medicine combination for treating diabetic peripheral neuropathy and preparation method thereof |
| 02/11/2009 | CN101361804A Enteral nutrition emulsion for tumor patient |
| 02/11/2009 | CN101361802A Traditional Chinese medicine formulation for treating diabetes complication disease |
| 02/11/2009 | CN101361800A Traditional Chinese medicine for reducing blood fat and enhancing effect and reducing toxin of statins medicine and preparation method thereof |
| 02/11/2009 | CN101361795A Medicine composition for treating cerebrovascular disease and quality control method thereof |
| 02/11/2009 | CN101361780A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361777A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361768A Diabetes treating medicine |
| 02/11/2009 | CN101361754A Use of rare-earth element salt or pharmaceutical composition thereof in preparing medicine for treating or preventing diabetes and adiposis |
| 02/11/2009 | CN101361734A Alpha-linolenic acid complexing agent |
| 02/11/2009 | CN101361585A Honeysuckle effervescence decoction piece and manufacture technique thereof |
| 02/11/2009 | CN101361513A Chinese herbal medicine live bacteria tea beverage capable of preventing and treating hypertension and preparation method thereof |
| 02/11/2009 | CN100460497C Blood fat reducing preparation and preparing method and use thereof |
| 02/11/2009 | CN100460414C Stable vitamin B6 derivative |
| 02/11/2009 | CN100459978C Rosiglitazone slow-release tablet and preparation method thereof |
| 02/11/2009 | CN100459975C Usage of D-glyceric acid or the salt thereof for preparing medical preparation strengthening alcohol metabolism |
| 02/11/2009 | CN100459881C Application of edestin for preparing functional food with adjuvant therapy of lowering blood fat |
| 02/10/2009 | US7488844 Therapeutic agents |
| 02/10/2009 | US7488829 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 02/10/2009 | US7488750 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 02/10/2009 | US7488727 Thiazole compounds useful as inhibitors of protein kinase |
| 02/10/2009 | US7488725 To treat diabetes, especially type II diabetes including complications of diabetes; synergistic |
| 02/10/2009 | US7488716 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 02/10/2009 | US7488715 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 02/10/2009 | US7488714 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 02/10/2009 | US7488710 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members |
| 02/10/2009 | US7488498 Controlled release nateglimide formulation; reducing blood glucose concentration |
| 02/10/2009 | CA2389709C Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 02/10/2009 | CA2294098C Novel thyroid receptor ligands and method |
| 02/10/2009 | CA2138558C Use of r-(+)-.alpha.-lipoic acid, r-(-)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae |
| 02/05/2009 | WO2009018441A1 Anti-cd28 antibodies for prolonging graft survival and treating type 1 diabetes |
| 02/05/2009 | WO2009018065A2 Novel glucokinase activators and methods of using same |
| 02/05/2009 | WO2009017755A2 Cb1 antagonists and inverse agonists |
| 02/05/2009 | WO2009017452A1 New crystalline forms of 2 -hydroxy- 3- [5- (morpholin- 4- ylmethyl) pyridin-2-yl] ih- indole- 5 -carbonitrile citrate |
| 02/05/2009 | WO2009017193A1 Amino-acid-containing medicinal granular preparation highly easy to take |
| 02/05/2009 | WO2009016462A2 Substituted bicyclolactam compounds |
| 02/05/2009 | WO2009016216A1 Triazole derivatives as scd inhibitors |
| 02/05/2009 | WO2009016119A1 Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type i and ii diabetes mellitus |
| 02/05/2009 | WO2009016118A1 Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type i and ii diabetes mellitus |
| 02/05/2009 | WO2009016088A1 The use of benzamide derivatives for the treatment of cns disorders |
| 02/05/2009 | WO2009015867A1 Substituted aryl or heteroarylpiperdine derivatives as melanocortin-4 receptor modulators |
| 02/05/2009 | WO2009015557A1 A pharmaceutical composition for treating diabetes and its process for preparation |
| 02/05/2009 | WO2009015547A1 A medicinal composition for the treatment of angiocadiopathy and hyperlipemia |
| 02/05/2009 | WO2009015515A1 A pharmaceutical composition for regulating blood sugar level and blood fat level, process for preparation and use thereof |
| 02/05/2009 | WO2009015485A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 02/05/2009 | WO2009015475A1 Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid |
| 02/05/2009 | WO2008150486A3 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| 02/05/2009 | WO2008108957A3 Piperidinyl-piperidine and piperazinyl-piperidine for use in the treatment of diabetes or pain |
| 02/05/2009 | WO2008036341A3 Compositions and methods relating to glucagon receptor antibodies |
| 02/05/2009 | WO2007003521A3 Pyridazine derivatives as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 02/05/2009 | WO2003099808A8 Substituted heterocyclic compounds and methods of use |
| 02/05/2009 | US20090038024 Cap/sorbs1 and diabetes |
| 02/05/2009 | US20090036682 Crystalline form of 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; used in the treatment of CNS and other disorders |
| 02/05/2009 | US20090036519 Peroxisome proliferator activated receptor ligand and process for producing the same |
| 02/05/2009 | US20090036508 Amino indazole derivatives |
| 02/05/2009 | US20090036503 Triazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1 |
| 02/05/2009 | US20090036489 Novel Cyclic Aminophenylalkanoic Acid Derivative |
| 02/05/2009 | US20090036476 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 02/05/2009 | US20090036472 Azabicyclo derivatives as anti-inflammatory agents |
| 02/05/2009 | US20090036471 Triazolopyrimidine Derivatives As Glycogen Synthase Kinase 3 Inhibitors |
| 02/05/2009 | US20090036461 Use of Azabicyclo Hexane Derivatives |
| 02/05/2009 | US20090036459 Melanocortin Type 4 Receptor Agonist Piperidinoylpyrrolidines |
| 02/05/2009 | US20090036450 Pyrazole compounds and use thereof |
| 02/05/2009 | US20090036449 Indazolesquaric Acid Derivatives as Chk1, Chk2 and Sgk Inhibitors |
| 02/05/2009 | US20090036448 Pyrimidine derivatives and methods of treatment related to the use thereof |
| 02/05/2009 | US20090036442 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/05/2009 | US20090036432 Combinations of AT1-antagonists, amiloride or triamterine, and a diuretic |
| 02/05/2009 | US20090036426 CB1 antagonists and inverse agonists |